GlassScriptPhysician profile
Sandy Danielle Turner
NPI 1164432001
$6,616.60
in general payments reported to CMS, 2019-2025
33 companies · $178 in 2025
The $178 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,281 · 2020: $1,196 · 2021: $2,939 · 2022: $389 · 2023: $274 · 2024: $361 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $812.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $812.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,265.84 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Amarin Pharma, INC. | $578.48 | 2019-2021 | |
| Abbvie INC. | $531.85 | 2019-2023 | Vraylar |
| Merck Sharp & Dohme LLC | $464.42 | 2019-2021 | |
| Amgen INC. | $393.54 | 2019-2021 | |
| Novo Nordisk INC | $362.66 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $315.50 | 2019-2021 | |
| Lilly USA, LLC | $253.45 | 2019-2021 | |
| Astellas Pharma US INC | $235.17 | 2019-2021 | |
| Genzyme Corporation | $226.12 | 2019-2023 | |
| Pfizer INC. | $203.31 | 2019-2021 | |
| Allergan, INC. | $185.26 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $160.97 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $155.23 | 2021-2024 | |
| Daiichi Sankyo INC. | $136.43 | 2019-2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $122.56 | 2019-2021 | |
| Axsome Therapeutics, INC. | $118.72 | 2024 | Auvelity |
| Sanofi-Aventis U.S. LLC | $105.56 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $94.46 | 2022 | |
| Glaxosmithkline, LLC. | $89.84 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $81.81 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $74.10 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $70.17 | 2019-2021 | |
| Vifor Pharma, INC. | $63.54 | 2020 | |
| Sunovion Pharmaceuticals INC. | $59.86 | 2020-2021 | |
| Ani Pharmaceuticals, INC. | $56.63 | 2025 | Purified Cortrophin Gel |
| Intuitive Surgical, INC. | $50.00 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $48.49 | 2019-2021 | |
| Alnylam Pharmaceuticals INC. | $40.95 | 2021 | |
| Si-Bone, INC. | $23.05 | 2020 | |
| Grifols USA, LLC | $18.10 | 2020 | |
| Hikma Pharmaceuticals USA | $17.50 | 2019 | |
| Boston Scientific Corporation | $13.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandy Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.